Diabetes & Endocrinology News
- Burned Out? Your Employer's Response May Surprise You
- Positive Topline Results for Antihypertensive Zilebesiran
- Insulet Shares Slump on Concerns of New Diabetes Drugs Sales
- Wegovy Received Is 'Very Small Fraction' of Waiting List
- Fracture Risk Factors Described in Ankylosing Spondylitis
- 20 Best Places for Doctors to Retire: 2023
- Ketogenic Diet Short-Term May Benefit Women With PCOS
- Schott Pharma to Provide Cartridges for Weight-Loss Drugs
- New AI-Enhanced Bandages Poised to Transform Wound Treatment
- ESC 2023 SGLT2i Safety in Acute Heart Failure Confirmed by New Data
- Georgia Can Resume Hormone Treatment Ban for Transgender Youth
- Obesity-Related Cardiovascular Disease Deaths Surging
- Abdominal Fat Linked to Lower Brain Volume in Midlife
- Wegovy Reaches Britain as NHS, Private Outlets Receive Weight Loss Drug
- Pent-Up Private Wegovy Demand Prompts UK Availability Concerns
- Novartis Sues US Government Over Medicare Drug Price Regulation
- Novo Nordisk Overtakes LVMH as Europe's Most Valuable Company
- Amgen Gets FTC Go-Ahead for $27.8 Billion Horizon Deal
- Launches of Novo Nordisk's Weight-Loss Drug Wegovy
- Wegovy Makes UK Weight-Loss Debut Despite Supply Struggles
- Even an Hour's Walk a Week Lowers Risk in Type 2 Diabetes
- Both Too Much and Not Enough Sleep Raises T2D Risk
- Apple Cider Vinegar, Fenugreek Best Herbal Remedies for T2D
- Jury Still Out on Stopping GLP-1 RAs Prior to Endoscopy
- UK's First Living Donor Uterus Transplant a Success
- As MOC Debate Heats Up, Cardiology Societies Weigh In
- Artificial Sweeteners Increase Cardiovascular Risk
- Firefighters Fight Fat With Mediterranean Diet Adoption
- A1c Not Linked to Postop Complications in Kids With Diabetes
- Biosimilars Comparable to Aflibercept in Macular Disease
- Only 1 in 4 Feel Fully Recovered Following COVID-19 Hospitalisation
- Call for Tighter LDL Targets for Highest Risk Patients